Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Analog Devices
ADI
|
+$121M |
| 4 |
United Therapeutics
UTHR
|
+$105M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$238M |
| 2 |
DXC Technology
DXC
|
+$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 4 |
NXP Semiconductors
NXPI
|
+$158M |
| 5 |
Baidu
BIDU
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.57% |
| 2 | Healthcare | 20.55% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 7.32% |
| 5 | Communication Services | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Church & Dwight Co
CHD
$23.4B
| $15.2M | 0.07% |
+177,947
| New | +$15.4M |
|
352
APA Corp
APA
$15.2B
| $15M | 0.07% |
695,229
-128,918
| -16% | -$2.65M |
|
353
Chemed
CHE
$7.07B
| $15M | 0.07% |
+31,600
| New | +$15.2M |
|
354
Bio-Techne
TECH
$11.3B
| $15M | 0.07% |
133,104
-255,088
| -66% | -$26.8M |
|
|
KIN
355
DELISTED
Kindred Biosciences, Inc.
KIN
| $14.9M | 0.07% |
1,620,476
-2,229,724
| -58% | -$13M |
|
356
ArcelorMittal
MT
$54.4B
| $14.7M | 0.07% |
473,500
+409,500
| +640% | +$12.7M |
|
|
FL
357
DELISTED
Foot Locker
FL
| $14.6M | 0.07% |
237,529
+219,929
| +1,250% | +$13.3M |
|
358
SolarEdge
SEDG
$1.9B
| $14.6M | 0.07% |
+52,741
| New | +$13.3M |
|
359
Trex
TREX
$4.77B
| $14.5M | 0.07% |
141,900
-22,600
| -14% | -$2.28M |
|
360
IDEAYA Biosciences
IDYA
$3.83B
| $14.5M | 0.07% |
689,945
-143,755
| -17% | -$2.95M |
|
361
XPeng
XPEV
$11.7B
| $14.5M | 0.06% |
+325,400
| New | +$11.1M |
|
|
BLU
362
DELISTED
BELLUS Health Inc.
BLU
| $14.4M | 0.06% |
4,640,648
-1,159,352
| -20% | -$4.43M |
|
363
Bausch Health
BHC
$2.41B
| $14.4M | 0.06% |
+491,400
| New | +$14.9M |
|
364
Praxis Precision Medicines
PRAX
$10.5B
| $14.4M | 0.06% |
52,466
+43,333
| +474% | +$15.5M |
|
365
Celanese
CE
$5.14B
| $14.4M | 0.06% |
94,800
+17,894
| +23% | +$2.84M |
|
366
Dyne Therapeutics
DYN
$4.87B
| $14.3M | 0.06% |
680,900
+327,785
| +93% | +$6.16M |
|
|
ORIO
367
Orion Digital Corp
ORIO
$21.3M
| $14.2M | 0.06% |
603,433
-17,467
| -3% | -$418K |
|
368
Outfront Media
OUT
$5.25B
| $14.2M | 0.06% |
600,393
-222,787
| -27% | -$5.16M |
|
369
Zurn Elkay Water Solutions
ZWS
$8.13B
| $14.2M | 0.06% |
588,494
-550,661
| -48% | -$13.2M |
|
370
CALL
Walmart Inc
WMT
$825B
| $14.1M | 0.06% |
+300,000
| New | +$14M |
|
371
Ormat Technologies
ORA
$6.67B
| $14M | 0.06% |
+201,900
| New | +$14.4M |
|
372
Dollar Tree
DLTR
$25.3B
| $14M | 0.06% |
140,817
-85,861
| -38% | -$9.33M |
|
|
AQUA
373
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $14M | 0.06% |
+413,779
| New | +$12.4M |
|
374
Herbalife
HLF
$1.33B
| $13.9M | 0.06% |
264,048
+59,200
| +29% | +$2.94M |
|
375
Tronox
TROX
$888M
| $13.9M | 0.06% |
619,253
+321,011
| +108% | +$7.05M |
|
Similar funds
Steven Cohen's Q2 2021 Portfolio in Review
As of Q2 2021, Steven Cohen held 1,274 positions worth $22.3B, up 4% from $21.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Steven Cohen's Q2 2021 filing shows 347 new, 260 increased, 248 reduced and 334 closed positions. Its largest new stake was United Therapeutics: 552,400 shares worth $99.1M. The largest sale was Applied Materials, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Steven Cohen's largest Q2 2021 buy was United Therapeutics: 552,400 shares worth $99.1M.
- Steven Cohen added most to Salesforce in Q2 2021, an estimated $372M increase.
- Steven Cohen's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $238M.
- Steven Cohen fully exited DXC Technology in Q2 2021, selling an estimated $235M.
- Steven Cohen's ten largest holdings make up 18% of its $22.3B portfolio in Q2 2021.
- Steven Cohen opened 347 new positions and closed 334 in Q2 2021.
- Steven Cohen's portfolio value rose 4% quarter-over-quarter to $22.3B.
Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.